Compare ZLAB & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | EQX |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 10.9B |
| IPO Year | 2017 | N/A |
| Metric | ZLAB | EQX |
|---|---|---|
| Price | $17.88 | $14.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $57.22 | $17.00 |
| AVG Volume (30 Days) | 841.3K | ★ 8.9M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | $441,629,000.00 | ★ $2,296,356,000.00 |
| Revenue This Year | $26.16 | $78.98 |
| Revenue Next Year | $30.62 | $29.11 |
| P/E Ratio | ★ N/A | $130.03 |
| Revenue Growth | 24.14 | ★ 85.65 |
| 52 Week Low | $16.82 | $4.95 |
| 52 Week High | $44.34 | $15.10 |
| Indicator | ZLAB | EQX |
|---|---|---|
| Relative Strength Index (RSI) | 36.77 | 53.35 |
| Support Level | $17.37 | $14.41 |
| Resistance Level | $19.01 | $15.03 |
| Average True Range (ATR) | 0.61 | 0.63 |
| MACD | 0.30 | -0.06 |
| Stochastic Oscillator | 47.49 | 35.42 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.